v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 18,963 $ 13,668
General and administrative 10,636 5,991
Total operating expenses 29,599 19,659
Loss from operations (29,599) (19,659)
Other income:    
Interest income 2,820 3,000
Other income 0 177
Total other income 2,820 3,177
Net loss $ (26,779) $ (16,482)
Net loss per share, basic (in dollars per share) $ (0.60) $ (0.62)
Net loss per share, diluted (in dollars per share) $ (0.60) $ (0.62)
Weighted-average number of common shares outstanding, basic (in shares) 44,921,984 26,596,059
Weighted-average number of common shares outstanding, diluted (in shares) 44,921,984 26,596,059
Comprehensive loss:    
Net loss $ (26,779) $ (16,482)
Unrealized loss on marketable securities (624) (67)
Total other comprehensive loss (624) (67)
Comprehensive loss $ (27,403) $ (16,549)